Exchange: NASDAQ·Updated 03:25 PM EDT
ALNY logo

ALNY Alnylam Pharmaceuticals Inc

$238.94
$2.93
(1.24%)
Today
Reported EarningsJul 30
Mkt Cap$31.58B
Vol743,401.00

About ALNY

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002, and is headquartered in Cambridge, MA.
38

Bearish Sentiment

How do you feel about ALNY?

Advertisement|Remove ads.